Genovate Biotechnology Co., Ltd. (TPEX:4130)

Genovate Biotechnology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	502.8	510.86	528.51	438.76	434.25	472.72
Revenue Growth (YoY)	-6.25%	-3.34%	20.46%	1.04%	-8.14%	1.50%
Cost of Revenue	318.95	318.21	317.6	283.89	284.5	279.62
Gross Profit	183.86	192.65	210.92	154.87	149.75	193.11
Selling, General & Admin	109.84	109.74	110.31	106.89	95.49	98.71
Research & Development	59.67	59.49	73.61	61.88	55.43	54.93
Operating Expenses	169.5	169.22	183.91	168.76	150.92	153.61
Operating Income	14.36	23.43	27.01	-13.89	-1.17	39.5
Interest Expense	-0.69	-0.52	-0.27	-0.28	-0.25	-0.25
Interest & Investment Income	6.53	6.5	5.02	2.67	1.61	2.17
Earnings From Equity Investments	-1.09	-0.96	-3.88	0.29	0.14	-1.63
Currency Exchange Gain (Loss)	0.61	0.43	0.21	0.44	-0.19	-0.17
Other Non Operating Income (Expenses)	2.29	1.71	2.29	1.65	3.44	1.23
EBT Excluding Unusual Items	22.01	30.59	30.39	-9.12	3.57	40.85
Gain (Loss) on Sale of Investments	0.47	0.47	0.45	0.07	-	0
Gain (Loss) on Sale of Assets	-	-	-	-	-	-0.09
Other Unusual Items	-	-	-0.01	0.05	-	-
Pretax Income	22.49	31.06	30.83	-9	3.57	40.76
Income Tax Expense	3.88	5.36	1.49	3.32	3.2	2.03
Net Income	18.61	25.7	29.33	-12.32	0.37	38.73
Net Income to Common	18.61	25.7	29.33	-12.32	0.37	38.73
Net Income Growth	-43.48%	-12.39%	-	-	-99.04%	13.73%
Shares Outstanding (Basic)	112	112	113	111	111	111
Shares Outstanding (Diluted)	112	113	113	111	111	111
Shares Change (YoY)	-0.51%	-0.22%	1.49%	-0.03%	-0.14%	-1.44%
EPS (Basic)	0.17	0.23	0.26	-0.11	0.00	0.35
EPS (Diluted)	0.17	0.23	0.26	-0.11	0.00	0.35
EPS Growth	-42.58%	-12.02%	-	-	-99.17%	15.34%
Free Cash Flow	59.34	24.34	56.81	-22.04	-35.22	60.07
Free Cash Flow Per Share	0.53	0.22	0.50	-0.20	-0.32	0.54
Dividend Per Share	0.100	0.100	0.146	0.170	0.340	0.390
Dividend Growth	-31.32%	-31.32%	-14.30%	-50.00%	-12.94%	-10.05%
Gross Margin	36.57%	37.71%	39.91%	35.30%	34.48%	40.85%
Operating Margin	2.85%	4.59%	5.11%	-3.17%	-0.27%	8.36%
Profit Margin	3.70%	5.03%	5.55%	-2.81%	0.09%	8.19%
Free Cash Flow Margin	11.80%	4.76%	10.75%	-5.02%	-8.11%	12.71%
EBITDA	49.7	58.01	60.9	19.94	32.33	72.32
EBITDA Margin	9.88%	11.36%	11.52%	4.54%	7.45%	15.30%
D&A For EBITDA	35.34	34.58	33.9	33.83	33.5	32.83
EBIT	14.36	23.43	27.01	-13.89	-1.17	39.5
EBIT Margin	2.85%	4.59%	5.11%	-3.17%	-0.27%	8.36%
Effective Tax Rate	17.27%	17.26%	4.84%	-	89.57%	4.97%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.